Daily Medical News

Postcall Podcast:
https://apple.co/2IeKD2y

1. GARFIELD-AF registry: DOACs cut mortality 19%
   http://bit.ly/2CFwmfe

2. Obesity paradox extends to PE patients
   http://bit.ly/2yvOILf

3. Adjuvanted flu vaccine reduces hospitalizations in oldest old
   http://bit.ly/2ITnnHq

4. Third trimester Tdap vaccination raises antibodies in newborns
   http://bit.ly/2Cb1Jx8

1. Guidelines outlines patient-centered approach to type 2 diabetes.
   (http://bit.ly/2Przga9)
   
   
2. With more mindfulness, menopausal symptoms wane. 
   (http://bit.ly/2ybN2Hk)
   
3. Employer health insurance: Deductibles rising faster than wages. 
   (http://bit.ly/2ybN2Hk)
   
4. Delayed pushing during labor does not benefit mother or baby.
    (http://bit.ly/2QC8sEq)
   

1. Bisphosphonate holiday may help reduce atypical femur fracture risk. (http://bit.ly/2QFvMkF)
   
   
2. Most dermatologic drugs safe for breastfeeding mothers. (http://bit.ly/2C7VLgn)
   
   
3. 'Twincreatin' produces 'impressive' HbA1c, weight control in T2DM. (http://bit.ly/2RBRIyp)
   
   
4. Short-term NSAIDs appear safe for high-risk patients.(http://bit.ly/2ONpv9e)

1. Half of outpatient antibiotics prescribed with no infectious disease code.
   https://www.mdedge.com/internalmedicinenews/article/176602/practice-management/half-outpatient-antibiotics-prescribed-no
   
2. How to vaccinate patients on biologics.
   https://www.mdedge.com/internalmedicinenews/article/176611/vaccines/how-vaccinate-patients-biologics
   
   
3. Opiate use tied to hepatitis C risk in youth.
   https://www.mdedge.com/internalmedicinenews/article/176570/hepatitis/opiate-use-tied-hepatitis-c-risk-youth
   
4. In rosacea, a single treatment may not be enough.
   https://www.mdedge.com/internalmedicinenews/article/176604/rosacea/rosacea-single-treatment-may-not-be-enough

1. FDA expands approval of 9-valent HPV vaccine to include men and women aged 27 - 45. 
   http://bit.ly/2zYfcHj
2. Allergen of the year may be closer than you think. 
   http://bit.ly/2y6FllH
3. Encourage influenza vaccination in pregnant women.
   http://bit.ly/2NtitBC
4. Sunscreens: Misleading labels, poor performance, and more.
   http://bit.ly/2y50M6G 

Sexual assault and harassment and the impact they have on women’s health. Also today, experts recommend anti-TNFs to for severe psoriasis in pregnancy, the FDA approves first-of-its-kind lung disease treatment, and do you know what the rive ontological emergencies are?

PCV13 shows moderate overall effectiveness for preventing invasive pneumococcal disease caused by PCV13 vaccine serotypes in adults 65 years and older (http://bit.ly/2QtUXGW). Also today, ED visits that are related to psychiatric complaints are up 20 among elderly (http://bit.ly/2xVmmus), nonobstructive angina should trigger functional testing (http://bit.ly/2Nk6TJk), and antibiotics trigger proteolytic activity that leads to chronic colitis (http://bit.ly/2zP0n9P).

Around one-half of women and, one-third of men will eventually develop dementia, stroke, or parkinsonism during their lifetime (http://bit.ly/2OxI0yh0). Also today, trivalent adjuvant influenza vaccine aIIV3 is safe in elderly adults (http://bit.ly/2P6MWqY) , pill burden affects the ability to reach systolic BP control (http://bit.ly/2P5LOUy), and breast cancer risk in type 2 diabetes related to adiposity (http://bit.ly/2NiOsVf).

Using aspirin across the board is not justified based on results of the ASPREE trial as well as on the equivocal results from other recent primary prevention trials (http://bit.ly/2Ophib1). Also today, swings in four metabolic measures predicted death in healthy people (http://bit.ly/2y4StXQ), anticoagulation plus single antiplatelet fails noninferiority measure 1 year after stenting (http://bit.ly/2Iuohdm), and Behavioral checklist identifies children at risk of depressive and/or anxiety disorders (http://bit.ly/2xRdHJr).

Hayden Bosworth, PhD has advice on how to get on top of home BP monitoring and how it can be clinically relevant (http://bit.ly/2QkMllQ). Also today, opioid use in osteoarthritis may mean more activity-limiting pain (http://bit.ly/2QlQqWN), sulfasalazine is pinpointed as the reason for high triple-therapy discontinuation (http://bit.ly/2DIyqoc), and point-of-care test for respiratory viruses lowers antibiotic use (http://bit.ly/2xRiLNM).

The National Foundation for Infectious Diseases advocates for vaccination for influenza (http://bit.ly/2N8ZRXE). Also today, the U.S. House and Senate agree on a broad opioid legislation (http://bit.ly/2OQ9lsh), a computerized tool could ease decision-making for lupus (http://bit.ly/2xXRrwA), and a proposed change to Part B drug reimbursement draws more fire from physician organizations (http://bit.ly/2QgYS9T).

Signs point to growing abuse of gabapentinoids in the United States. Short sleep is linked to elevated blood pressure. Another large trial shows CT screening reduces lung cancer deaths. And atrial fibrillation guidelines may miss the mark with oral anticoagulation.

A pediatric psychiatric consult for adolescent and adult ADHD by Sarah E. Guth, MD (http://bit.ly/2IiA6Dy). Also today, prosthesis-patient mismatch post TAVR ups the risk of death by 19% (http://bit.ly/2zshtdw), residents help to curb the overuse of IV antibiotics in children (http://bit.ly/2IhySsg), and both age and other risk factors ought to guide chlamydia and gonorrhea screening for women infected with HIV (http://bit.ly/2ztaT6E).

You can subscribe to the Postcall Podcast ahead of the first episode (https://apple.co/2IeKD2y)

Ketamine may be helpful in central sensitization pain syndromes (http://bit.ly/2O5TN6F). Also today, trifarotene cream for acne meats all endpoints in twin phase 3 trials (http://bit.ly/2xJ5GGz), the pros and cons of gastric bypass surgery for patients with type 2 diabetes (http://bit.ly/2OOam4m), and it looks like obesity plays a role in sleep-disordered breathing for pregnant women (http://bit.ly/2px9yWr).

Bleeding from rivaroxaban may help diagnose some GI and GU cancers (http://bit.ly/2O6YfCf [Cardiocast: http://bit.ly/2xJNOdv]). Also today, a review by the FDA supports the safety of nuplazid (http://bit.ly/2pxT5Bw), arthritis is prevalent in older adults with any degree of depression (http://bit.ly/2xxTXug), and growth in overdose deaths is exponential (http://bit.ly/2xIHG5xf).

Dr. Joseph Murray of the Mayo Clinic points out that you might know as much about celiac as you think (http://bit.ly/2preFr4).

Also today, a novel agent shows unprecedented efficacy in psoriasis (http://bit.ly/2MLLE2I), IgA vasculitis may be more common in adults than you think (http://bit.ly/2DeXTFC), and one-step gestational diabetes screening doesn’t improve outcomes (http://bit.ly/2xy7VLM).

The U.S. Preventative Services Task Force advises clinicians to refer or offer intensive behavioral weight-loss interventions to obese adults (http://bit.ly/2DbYO9F). Also today, stop treating gout and start curing it (http://bit.ly/2QIhaBO) the FDA has a new risk evaluation mitigation strategy for immediate-release opioids (http://bit.ly/2Df9AvY), and the United Nations aims to eradicate tuberculosis by the year 2030 (http://bit.ly/2DenEFN).

Researchers found evidence of impaired white matter integrity on MRI in a handful of hypertensive children similar to what is found in adults with cognitive impairment from hypertension (http://bit.ly/2NR9MWc). Also today, predictors for worse outcomes in low–disease activity RA remain tough to come by (http://bit.ly/2MMZ4M1), elevated type 2 diabetes risk seen in PsA patients (http://bit.ly/2NjOAZo), and new European hypertension guidelines target most adults to less than 130/80 mm Hg (http://bit.ly/2OAmLsv).

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months (http://bit.ly/2QD0U4U). Also today, the FDA approves Ajovy for migraine prevention(http://bit.ly/2Nhbxwq), some teens are using cannabis in their vapor devices (http://bit.ly/2pekqs7), and alpha-blocker use is still common and still risky (http://bit.ly/2No2QAE).

More than half of patients who were tested for prescription drug compliance last year misused their medications (http://bit.ly/2xpqou1). Also today, obesity prevalence is now at least 35% in 7 states(http://bit.ly/2NLI3WW), the FDA has a new plan to combat antibiotic resistance (http://bit.ly/2MCBykL), and what will come of all the comments about the new E/M payment proposals (http://bit.ly/2xryMZM).